These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21184080)

  • 1. Combined therapy associating systemic platinum-based chemotherapy and local radiotherapy into the treatment of primary intraocular lymphoma.
    Tempescul A; Pradier O; Marianowski-Cochard C; Ianotto JC; Berthou C
    Ann Hematol; 2011 Sep; 90(9):1117-8. PubMed ID: 21184080
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions and answers in the management of primary central nervous system and ocular lymphomas.
    Ferreri AJ; Dell'oro S; Reni M; Foppoli M; Anzalone N; Govi S; Picozzi P; Truci G; Ponzoni M
    Haematologica; 2003 Sep; 88(9):1063-8. PubMed ID: 12969815
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraocular lymphoma: report of three cases and review of the literature.
    Trudeau M; Shepherd FA; Blackstein ME; Gospodarowicz M; Fitzpatrick P; Moffatt KP
    Am J Clin Oncol; 1988 Apr; 11(2):126-30. PubMed ID: 3282423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravitreal chemotherapy for intraocular lymphoma].
    Helbig H; Cerny T; de Smet MD
    Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy.
    Berenbom A; Davila RM; Lin HS; Harbour JW
    Eye (Lond); 2007 Sep; 21(9):1198-201. PubMed ID: 16732210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
    Itty S; Olson JH; O'Connell DJ; Pulido JS
    Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
    [No Abstract]   [Full Text] [Related]  

  • 7. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
    Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
    Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma.
    Woolf DK; Ahmed M; Plowman PN
    Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):339-44. PubMed ID: 22521959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical review: treatment of vitreoretinal lymphoma.
    Pe'er J; Hochberg FH; Foster CS
    Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary intraocular lymphoma: current and future perspectives.
    Dunleavy K; Wilson WH
    Leuk Lymphoma; 2006 Sep; 47(9):1726-7. PubMed ID: 17064977
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in the management of intraocular lymphoma.
    Strauchen JA; Dalton J; Friedman AH
    Cancer; 1989 May; 63(10):1918-21. PubMed ID: 2702565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intraocular lymphoma with high-dose Ara-C.
    Baumann MA; Ritch PS; Hande KR; Williams GA; Topping TM; Anderson T
    Cancer; 1986 Apr; 57(7):1273-5. PubMed ID: 2418934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate.
    de Smet MD
    Bull Soc Belge Ophtalmol; 2001; (279):91-5. PubMed ID: 11344720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
    Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).
    Koch P; Probst A; Berdel WE; Willich NA; Reinartz G; Brockmann J; Liersch R; del Valle F; Clasen H; Hirt C; Breitsprecher R; Schmits R; Freund M; Fietkau R; Ketterer P; Freitag EM; Hinkelbein M; Heinecke A; Parwaresch R; Tiemann M
    J Clin Oncol; 2005 Oct; 23(28):7050-9. PubMed ID: 16129843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI
    Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Full-dose CHOP chemotherapy--feasibility and influence upon radiotherapy].
    Tominaga S; Kondo M; Ando Y; Yamashita S; Uematsu M; Shigematsu N; Nishiguchi I; Hashimoto S
    Nihon Gan Chiryo Gakkai Shi; 1985 Aug; 20(7):1327-33. PubMed ID: 3841142
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.